Abbott Ups Emerging Markets Ante With Zydus Deal, Established Products Unit

The acquisition of Solvay's pharmaceutical unit, completed in February, gave Abbott a substantial branded generics business and strengthened its international presence. Now the company is looking to build on those assets with an enhanced emerging market strategy